Lee et al.41 demonstrated that CD133+ cells had a higher tumorigenic potential and higher rates of metastasis to the lung than CD44+ cells, suggesting that CD133 is implicated in the aggressive behavior of pancreatic cancer. This evidence concerns the gene PROM1 and familial pancreatic carcinoma.